Lansing Street Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
6,198
+10
+0.2% +$2.33K 0.33% 53
2026
Q1
$1.51M Buy
6,188
+28
+0.5% +$6.52K 0.38% 48
2025
Q4
$1.27M Buy
6,160
+61
+1% +$12.1K 0.33% 57
2025
Q3
$1.13M Buy
6,099
+297
+5% +$50.9K 0.3% 62
2025
Q2
$886K Sell
5,802
-18
-0.3% -$2.77K 0.26% 66
2025
Q1
$965K Buy
5,820
+154
+3% +$24.1K 0.32% 50
2024
Q4
$819K Buy
5,666
+59
+1% +$9.14K 0.29% 49
2024
Q3
$909K Buy
5,607
+101
+2% +$16.1K 0.33% 46
2024
Q2
$805K Buy
5,506
+170
+3% +$25.3K 0.34% 48
2024
Q1
$844K Buy
5,336
+1,076
+25% +$171K 0.38% 50
2023
Q4
$668K Buy
+4,260
New +$653K 0.35% 51
2023
Q2
$695K Buy
4,197
+31
+0.7% +$5K 0.4% 49
2023
Q1
$646K Buy
4,166
+22
+0.5% +$3.55K 0.4% 48
2022
Q4
$732K Buy
4,144
+83
+2% +$14.3K 0.5% 43
2022
Q3
$664K Buy
4,061
+176
+5% +$29.8K 0.51% 41
2022
Q2
$690K Sell
3,885
-3
-0.1% -$535 0.54% 40
2022
Q1
$708K Buy
+3,888
New +$662K 0.45% 44

Other funds holding JNJ

Lansing Street Advisors's JNJ Position: Q2 2026 in Review

Lansing Street Advisors increased its Johnson & Johnson (JNJ) stake by 0.16% in Q2 2026, buying an estimated $2.33K and bringing the position to 6,198 shares worth $1.57M. The position accounts for 0.33% of the portfolio, ranked #53.

Lansing Street Advisors first reported a position in JNJ in Q1 2022 and has held it in 17 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lansing Street Advisors held 6,198 shares of Johnson & Johnson worth $1.57M as of Q2 2026.
  • Lansing Street Advisors bought 10 Johnson & Johnson shares in Q2 2026, an estimated $2.33K.
  • Johnson & Johnson made up 0.33% of Lansing Street Advisors's portfolio in Q2 2026, its #53 holding.
  • Lansing Street Advisors first reported a position in Johnson & Johnson in Q1 2022 and has held it in 17 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lansing Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.